Home  >  News
 Eppen_DNALoBind_Jun24
you can get e-magazine links on WhatsApp. Click here
News
  Botnar Institute of Immune Engineering launches new global research centre in Switzerland,   June 19, 2024
  Wanbury's Patalganga manufacturing facility clears US FDA inspection with zero observations,   June 19, 2024
  AstraZeneca’s CAPItello-290 phase III trial of Truqap plus chemotherapy in advanced or metastatic TNBC fails to meet dual primary endpoints,   June 19, 2024
  Merck’s Capvaxive gets US FDA approval for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults,   June 19, 2024
  Sellas Life Sciences receives IDMC recommendation to continue phase 3 REGAL trial in acute myeloid leukaemia,   June 18, 2024
  NIH-funded intervention did not impact opioid-related overdose death rates over evaluation period,   June 18, 2024
  Aprea Therapeutics begins patient dosing in ACESOT-1051 phase 1 trial evaluating oral WEE1 inhibitor APR-1051,   June 18, 2024
  Rare disease patients appeal health minister to ensure sustained funding and policy intervention,   June 18, 2024
  Innate Pharma announces updated results from the Sanofi developed blood cancer phase 1/2 SAR443579/IPH6101 trial,   June 18, 2024
  NW Bio announces exclusive in-license of portfolio of dendritic cell technology and intellectual property,   June 18, 2024
  AstraZeneca announces positive results from ECHO phase III trial of Calquence in combo with bendamustine & rituximab to treat patients with untreated mantle cell lymphoma,   June 18, 2024
  Raya Therapeutic announces supportive clinical results of fasudil in amyotrophic lateral sclerosis patients,   June 18, 2024
  MGI Tech, SeqOne partner to advance end-to-end genomic analysis,   June 18, 2024
  Vapotherm signs definitive merger agreement with an affiliate of Perceptive Advisors,   June 18, 2024
  Takeda announces positive results from phase 3 study of soticlestat in patients with Dravet syndrome and Lennox-Gastaut syndrome,   June 18, 2024
  AstraZeneca’s Imfinzi plus chemotherapy receives US FDA approval for mismatch repair deficient advanced or recurrent endometrial cancer,   June 18, 2024
  Cabaletta Bio announces positive initial clinical data from phase 1/2 RESET-Myositis and RESET-SLE trials of CABA-201,   June 17, 2024
  Emergency Scientific announces new FDA cleared balloon catheter used for vessel occlusion during patient resuscitation,   June 17, 2024
  EPAM acquires Odysseus to transform the life sciences value chain with advanced analytics, data methods and AI,   June 17, 2024
  Immune-Onc presents additional data from IO-202 phase 1b trials in patients with CML at 2024 EHA Annual Congress,   June 17, 2024

 Back
 
avians24_PB
CPHISEA24
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram